Internal Medicine, Infectious Disease · Beverly Hills, CA
NPI
1114952496
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
8641 Wilshire Blvd, Suite 100
Beverly Hills, CA, 90211
Phone (310) 657-0367
Groups this clinician bills Medicare through
Medicare paid, 2024
$495K
20,676 services
Medicare patients, 2024
448
Average age 74
Drug cost, 2024
$3.3M
3,606 prescriptions
Company payments, 2025
$955
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aaron Perlmutter was code J1071 (injection, testosterone cypionate, 1 mg), 11,800 times for 15 patients. In total Aaron Perlmutter billed 20,676 services in 16 codes, and Medicare paid $495K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1071 Injection, testosterone cypionate, 1 mg | Office | 11,800 | 15 | $0.01 | $156 |
| 99233 Hospital E&M - Subsequent | Facility | 3,104 | 338 | $99.01 | $307K |
| 99223 Hospital E&M - Initial | Facility | 397 | 299 | $143.81 | $57K |
| 99291 Critical Care E&M | Facility | 346 | 41 | $176.09 | $61K |
| 99214 Office E&M - Established | Office | 284 | 84 | $105.29 | $30K |
| 99215 Office E&M - Established | Office | 198 | 92 | $152.57 | $30K |
| 96372 Injection Administration | Office | 143 | 23 | $11.06 | $1,581 |
| 99205 Office E&M - New | Office | 21 | 21 | $191.32 | $4,018 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 15 | 12 | $88.58 | $1,329 |
By year: 2022 $510K for 49,730 services; 2023 $494K for 27,030 services; 2024 $495K for 20,676 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aaron Perlmutter prescribed most often to Medicare patients was Oxycodone Hcl, with 145 prescriptions and refills. In total Aaron Perlmutter wrote 3,606 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 145 | 145 | 14 | $3,997 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 143 | 153 | 14 | $604K |
| Alprazolam Generic | 129 | 133 | 16 | $697 |
| Gabapentin Generic | 122 | 142 | 14 | $969 |
| Atorvastatin Calcium Generic | 109 | 159 | 19 | $684 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 95 | 95 | 14 | $2,674 |
| Tamsulosin Hcl Generic | 87 | 101 | 13 | $498 |
| Rosuvastatin Calcium Generic | 83 | 109 | 11 | $723 |
| Juluca Dolutegravir/Rilpivirine | 73 | 73 | Under 11 | $247K |
| Amlodipine Besylate Generic | 70 | 98 | 11 | $131 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 69 | 81 | 13 | $2,370 |
| Metformin Hcl Generic | 66 | 108 | 12 | $131 |
| Ozempic Semaglutide | 60 | 71 | Under 11 | $65K |
| Serostim Somatropin | 58 | 58 | Under 11 | $1.1M |
| Acyclovir Generic | 55 | 55 | Under 11 | $232 |
Brand drugs: - claims; generic drugs: 2,660 claims; opioid claims: 323.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aaron Perlmutter $955 ($955 in general payments such as food, travel and fees) from 9 companies. The largest payer was ViiV Healthcare Company with $408.
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company GSK | 15 | $408 |
| Gilead Sciences, Inc. GILD | 4 | $302 |
| Kestra Medical Technology Services, Inc. | 2 | $52.03 |
| Merck Sharp & Dohme LLC MRK | 2 | $50.23 |
| Verity Pharmaceuticals Inc. | 1 | $34.19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $31.51 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $26.81 |
| EMD Serono, Inc. MRK.DE | 1 | $26.44 |
| Heartflow, Inc. HTFL | 1 | $23.99 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.